PHILADELPHIA--(BUSINESS WIRE)--BioAdvance, a leading seed-stage investor in life sciences companies, announced today that it is accepting proposals for funding from eligible start-up companies and institutions on a rolling basis. In addition to accepting applications throughout the year, BioAdvance has streamlined its process to allow corporate applicants to submit a business plan instead of preparing a formal application.
